Pfizer vs Moderna Vaccine

Moderna gets $590M from US government

As bird flu becomes a growing threat, Moderna is awarded $590M to develop mRNA pandemic influenza vaccines

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even probable.

BioPharma Dive · 1d

Moderna gets $590M from US government for bird flu vaccine

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats. Others, including GSK and Pfizer, are also at work on similar shots.

U.S. News & World Report · 1d

Moderna Receives $590M From HHS to Develop Bird Flu Vaccine

The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu. This funding, announced Friday by Moderna,

Hosted on MSN · 1d

Moderna Is Getting $590 Million From the U.S. to Accelerate a Bird Flu Vaccine

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Investopedia on MSN · 1d

Moderna Stock Jumps as Biotech Gets $590M From US To Develop Bird-Flu Vaccine

Key Takeaways Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu.The biotech firm's mRNA-1018 candidate posted positive results in a Phase 1/2 study launched in 2023.

Channel NewsAsia Singapore2h

Updated Novavax COVID-19 vaccine available at some GP clinics until Apr 30

SINGAPORE: The updated JN.1 Novavax/Nuvaxovid COVID-19 vaccine will be offered under the national vaccination programme at ...

infectiousdiseaseadvisor.com17h

COVID-19 Vaccines Do Not Increase Risk for Thyroid Diseases

COVID-19 vaccines were not associated with increased risk for thyroid diseases but were associated with increased risk for exacerbated hypothyroidism.

Updated Novavax Covid-19 vaccine available in S’pore from Jan 24 to April 30: MOH

SINGAPORE - People who are eligible for the Novavax Covid-19 vaccine can go to selected clinics from Jan 24 to April 30 for ...

MedCity News7d

Pfizer CEO At JPM Issues Clear Warning to Kennedy on Vaccines

Aside from Pfizer, other companies were also asked if they expect any changes from the incoming administration on vaccines. The CEO of Moderna, which created the mRNA Covid vaccine, and has ...

7don MSN

Down 79%, Is Moderna Stock a Bad-News Buy on the Dip?

Moderna (NASDAQ: MRNA) shareholders have been having a rough time lately. The biotech stock rocketed higher last spring, but ...

FiercePharma9d

JPM25: Moderna slashes guidance, plots $1B in cost cuts this year amid lackluster vaccine sales

Stéphane Bancel, CEO of mRNA specialist Moderna, delivered some difficult truths to shareholders about the company’s ...

Moderna cuts sales forecast on weaker vaccine demand

Moderna ( MRNA) cut its 2025 forecast by $1 billion Monday, citing weak demand for its newest vaccine as well as slow sales ...

Is Moderna a Bad-News Buy for 2025?

At the healthcare conference, Moderna lowered expected 2025 revenue to the range of $1.5 billion to $2.5 billion -- down from ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results